Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO00540)
Xenobiotics Name
Artesunate
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Drug in Phase 2 Clinical Trial
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6917864"></iframe>
3D MOL 2D MOL
PubChem CID
6917864
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Glutathione S-transferase pi (GSTP1) DME Info Homo sapiens [1]
DME(s) Induced by This Xenobiotics
Catalase (CAT) DME Info Homo sapiens [2], [1]
References
1 Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate. Int J Oncol. 2009 Jul;35(1):149-58.
2 Factors determining sensitivity or resistance of tumor cell lines towards artesunate. Chem Biol Interact. 2010 Apr 15;185(1):42-52.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.